Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 33 | 2020 | 2887 | 2.280 |
Why?
|
| Magnetic Resonance Imaging | 27 | 2018 | 3352 | 1.940 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 111 | 0.760 |
Why?
|
| Breast | 8 | 2020 | 286 | 0.750 |
Why?
|
| Contrast Media | 14 | 2015 | 1077 | 0.720 |
Why?
|
| Mammography | 4 | 2017 | 461 | 0.660 |
Why?
|
| Calcinosis | 1 | 2017 | 224 | 0.560 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2012 | 156 | 0.520 |
Why?
|
| Gadolinium DTPA | 8 | 2015 | 261 | 0.500 |
Why?
|
| Sensitivity and Specificity | 11 | 2017 | 1990 | 0.460 |
Why?
|
| ROC Curve | 8 | 2020 | 752 | 0.430 |
Why?
|
| Retrospective Studies | 17 | 2018 | 8475 | 0.410 |
Why?
|
| Middle Aged | 32 | 2020 | 25017 | 0.370 |
Why?
|
| Image Enhancement | 6 | 2015 | 563 | 0.350 |
Why?
|
| Ultrasonography, Mammary | 3 | 2018 | 82 | 0.350 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 332 | 0.320 |
Why?
|
| Aged | 22 | 2018 | 18402 | 0.310 |
Why?
|
| Female | 33 | 2020 | 44507 | 0.300 |
Why?
|
| Adult | 24 | 2020 | 25640 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2015 | 663 | 0.290 |
Why?
|
| Mastectomy, Segmental | 2 | 2012 | 92 | 0.280 |
Why?
|
| Observer Variation | 4 | 2016 | 602 | 0.270 |
Why?
|
| Reproducibility of Results | 9 | 2018 | 2705 | 0.250 |
Why?
|
| Biopsy | 6 | 2015 | 1161 | 0.250 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 6501 | 0.210 |
Why?
|
| Humans | 37 | 2020 | 86601 | 0.210 |
Why?
|
| Kinetics | 5 | 2016 | 1513 | 0.190 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 1565 | 0.190 |
Why?
|
| Echo-Planar Imaging | 1 | 2020 | 52 | 0.180 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 294 | 0.180 |
Why?
|
| Lymphatic Metastasis | 4 | 2016 | 481 | 0.180 |
Why?
|
| Breast Diseases | 2 | 2016 | 97 | 0.160 |
Why?
|
| Cryosurgery | 1 | 2018 | 40 | 0.160 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2017 | 14 | 0.160 |
Why?
|
| Nipples | 1 | 2018 | 36 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2006 | 2600 | 0.150 |
Why?
|
| Resuscitation | 1 | 1998 | 100 | 0.150 |
Why?
|
| Axilla | 2 | 2013 | 97 | 0.130 |
Why?
|
| Entropy | 1 | 2015 | 38 | 0.130 |
Why?
|
| Probability | 1 | 2015 | 355 | 0.130 |
Why?
|
| Heart Arrest | 1 | 1998 | 265 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 307 | 0.120 |
Why?
|
| Carcinoma | 1 | 2018 | 436 | 0.120 |
Why?
|
| Algorithms | 3 | 2011 | 1830 | 0.120 |
Why?
|
| Hyperostosis, Sternocostoclavicular | 1 | 1993 | 1 | 0.120 |
Why?
|
| Chest Pain | 1 | 1993 | 42 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 1 | 2015 | 462 | 0.110 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 1937 | 0.110 |
Why?
|
| Water | 2 | 2012 | 275 | 0.100 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 392 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2018 | 468 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 552 | 0.090 |
Why?
|
| False Negative Reactions | 1 | 2010 | 63 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 857 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2011 | 217 | 0.090 |
Why?
|
| Fourier Analysis | 1 | 2009 | 125 | 0.090 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 53 | 0.090 |
Why?
|
| Lymph Nodes | 2 | 2016 | 530 | 0.090 |
Why?
|
| Prognosis | 4 | 2015 | 3674 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 1204 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 235 | 0.070 |
Why?
|
| Area Under Curve | 2 | 2020 | 334 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 579 | 0.070 |
Why?
|
| Hyponatremia | 1 | 2003 | 25 | 0.060 |
Why?
|
| Alcoholism | 1 | 2003 | 172 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2005 | 1538 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3636 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1685 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1464 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2015 | 839 | 0.050 |
Why?
|
| Radiography | 2 | 2012 | 813 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1673 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2005 | 7988 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 1313 | 0.040 |
Why?
|
| Hospitals, Municipal | 1 | 1998 | 1 | 0.040 |
Why?
|
| Emergency Medical Technicians | 1 | 1998 | 14 | 0.040 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 2018 | 8 | 0.040 |
Why?
|
| Electric Countershock | 1 | 1998 | 47 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1998 | 45 | 0.040 |
Why?
|
| Sudden Infant Death | 1 | 1998 | 25 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 91 | 0.040 |
Why?
|
| Ventricular Fibrillation | 1 | 1998 | 65 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2020 | 4210 | 0.040 |
Why?
|
| Japan | 1 | 1998 | 307 | 0.040 |
Why?
|
| Patient Transfer | 1 | 1998 | 91 | 0.040 |
Why?
|
| Brain Diseases | 1 | 1998 | 180 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 187 | 0.040 |
Why?
|
| Mastectomy | 1 | 2018 | 236 | 0.030 |
Why?
|
| Lung Diseases | 1 | 1998 | 263 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 317 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2018 | 394 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1998 | 190 | 0.030 |
Why?
|
| Heart Diseases | 1 | 1998 | 290 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2005 | 2207 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1995 | 66 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1204 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 1995 | 130 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 68 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 751 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 1998 | 484 | 0.030 |
Why?
|
| Survival Rate | 1 | 1998 | 1860 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 999 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 1993 | 220 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 375 | 0.030 |
Why?
|
| Fats | 1 | 2011 | 12 | 0.030 |
Why?
|
| Mass Screening | 1 | 2016 | 617 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2012 | 303 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1849 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2767 | 0.030 |
Why?
|
| Bone and Bones | 1 | 1993 | 265 | 0.030 |
Why?
|
| Infant | 1 | 1998 | 3045 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2011 | 133 | 0.020 |
Why?
|
| Injections | 1 | 2010 | 109 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2010 | 121 | 0.020 |
Why?
|
| Psoriasis | 1 | 1993 | 240 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 396 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2010 | 95 | 0.020 |
Why?
|
| Male | 4 | 2003 | 40956 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 1993 | 827 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1961 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2007 | 695 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5416 | 0.020 |
Why?
|
| Thallium Radioisotopes | 1 | 1995 | 5 | 0.010 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 1995 | 7 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 52 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1995 | 90 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1995 | 244 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1995 | 232 | 0.010 |
Why?
|
| Heart | 1 | 1995 | 539 | 0.010 |
Why?
|